MENK therapy induced up-regulation of CD86, CD40, IL-12, and TNF-α, but had no effect on CD163, IL-10, and TGF-β.
A high phagocytosis capacity and increased expression of ROS, nitrite and iNOS were observed in MENK-treated microglia.
Supernatants from MENK-treated microglia induced cytotoxicity against glioblastoma cells.